Mark Liu, MHA

Mark Liu, MHA, is Senior Director of Oncology Strategy, Transformation and Analytics for the oncology service line at the Mount Sinai Health System, an integrated health system across the five boroughs of New York City that includes eight hospitals and multiple ambulatory sites. He works closely with senior leadership to develop long-term strategy and also collaborates on critical projects in clinical quality, alternative payment models, new technologies, and process improvement. Prior to joining Mount Sinai in 2015, Mark managed outpatient operations for solid and hematologic cancers at Memorial Sloan Kettering Cancer Center.

Mark holds a Master of Healthcare Administration from the Mailman School of Public Health at Columbia University and a Bachelor of Science in both Integrated Neuroscience and Sociology from Binghamton University. He was named a Fellow in the Association of Cancer Executives Administrative Fellowship Program in 2021 and was elected to serve on their Board of Directors in 2022. Mark was selected as one of 25 scholars in the 2022 American College of Healthcare Executives' Thomas C. Dolan Career Accelerator Program. Most recently, he was inducted as a lifetime Fellow of the Association of Community Cancer Centers and is the 2023-2025 Editor in Chief of their official journal, Oncology Issues.